[
  {
    "ts": "2025-10-16T22:06:06+00:00",
    "headline": "Why Kenvue Stock Tumbled by 13% on Thursday",
    "summary": "The company's baby powder product is under legal fire once again.",
    "url": "https://www.fool.com/investing/2025/10/16/why-kenvue-stock-tumbled-by-13-on-thursday/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "291abcaa-6eb8-395e-ab3d-fe6b9bd01bf7",
      "content": {
        "id": "291abcaa-6eb8-395e-ab3d-fe6b9bd01bf7",
        "contentType": "STORY",
        "title": "Why Kenvue Stock Tumbled by 13% on Thursday",
        "description": "",
        "summary": "The company's baby powder product is under legal fire once again.",
        "pubDate": "2025-10-16T22:06:06Z",
        "displayTime": "2025-10-16T22:06:06Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/1f458d03fcc89fc5c32600a96a9f1aed",
          "originalWidth": 1400,
          "originalHeight": 931,
          "caption": "Concerned young person with head in hands gazing at a screen.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZFTvymmhtfsqraJhP30ugg--~B/aD05MzE7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/1f458d03fcc89fc5c32600a96a9f1aed.cf.webp",
              "width": 1400,
              "height": 931,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ud3a1WXbRxujUBSlMJMThw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/1f458d03fcc89fc5c32600a96a9f1aed.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/10/16/why-kenvue-stock-tumbled-by-13-on-thursday/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-kenvue-stock-tumbled-13-220606397.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "KVUE"
            },
            {
              "symbol": "^SPX"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-16T20:50:10+00:00",
    "headline": "Kenvue Stock Falls 13% in Its Worst Day on Record",
    "summary": "Shares of Kenvue fell 13% Thursday to $14.11, its lowest finish since the consumer healthcare firm spun off from Johnson & Johnson in 2023.  The decline was the sharpest on record for Kenvue, according to Dow Jones Market Data.  The fall surpassed the day last month that President Trump warned that the active ingredient in Kenvue's Tylenol is a potential cause of autism.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-10-16-2025/card/kenvue-stock-falls-13-in-its-worst-day-on-record-zM9bOy3odwhZFpgTMD1p?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "f7734e43-9bb7-34f7-b09b-d9de586ad489",
      "content": {
        "id": "f7734e43-9bb7-34f7-b09b-d9de586ad489",
        "contentType": "STORY",
        "title": "Kenvue Stock Falls 13% in Its Worst Day on Record",
        "description": "",
        "summary": "Shares of Kenvue fell 13% Thursday to $14.11, its lowest finish since the consumer healthcare firm spun off from Johnson & Johnson in 2023.  The decline was the sharpest on record for Kenvue, according to Dow Jones Market Data.  The fall surpassed the day last month that President Trump warned that the active ingredient in Kenvue's Tylenol is a potential cause of autism.",
        "pubDate": "2025-10-16T20:50:10Z",
        "displayTime": "2025-10-16T20:50:10Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/f7734e43-9bb7-34f7-b09b-d9de586ad489/kenvue-stock-falls-13-in-its.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8",
          "originalWidth": 1200,
          "originalHeight": 630,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AC.ajdS9OghfMNW3mzlvpg--~B/aD02MzA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8.cf.webp",
              "width": 1200,
              "height": 630,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J5JxVR9DmLuomtxdXBS7Uw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-10-16-2025/card/kenvue-stock-falls-13-in-its-worst-day-on-record-zM9bOy3odwhZFpgTMD1p?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "KVUE"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-16T19:37:28+00:00",
    "headline": "Johnson & Johnson’s (JNJ) Stock Is Now Positioned To “Challenge Eli Lilly,” Says Jim Cramer",
    "summary": "We recently published Jim Cramer Talked About These 8 Stocks & The Quantum Computing Dip. Johnson & Johnson (NYSE:JNJ) is one of the stocks Jim Cramer recently discussed. Johnson & Johnson (NYSE:JNJ) announced yesterday that it would spin off its orthopedics business to allow it to become the largest firm of its kind in the […]",
    "url": "https://finance.yahoo.com/news/johnson-johnson-jnj-stock-now-193728098.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "a7886cdd-3a04-3230-b7b1-fb1b2a9af2e6",
      "content": {
        "id": "a7886cdd-3a04-3230-b7b1-fb1b2a9af2e6",
        "contentType": "STORY",
        "title": "Johnson & Johnson’s (JNJ) Stock Is Now Positioned To “Challenge Eli Lilly,” Says Jim Cramer",
        "description": "",
        "summary": "We recently published Jim Cramer Talked About These 8 Stocks & The Quantum Computing Dip. Johnson & Johnson (NYSE:JNJ) is one of the stocks Jim Cramer recently discussed. Johnson & Johnson (NYSE:JNJ) announced yesterday that it would spin off its orthopedics business to allow it to become the largest firm of its kind in the […]",
        "pubDate": "2025-10-16T19:37:28Z",
        "displayTime": "2025-10-16T19:37:28Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/5ebeb797976f4b134f89e7fc0f1f7cd5",
          "originalWidth": 848,
          "originalHeight": 565,
          "caption": "Johnson & Johnson's (JNJ) Stock Is Now Positioned To \"Challenge Eli Lilly,\" Says Jim Cramer",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qjhajy_X8xr_FpnwS8Zrgg--~B/aD01NjU7dz04NDg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/5ebeb797976f4b134f89e7fc0f1f7cd5.cf.webp",
              "width": 848,
              "height": 565,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5LsSqgRtcwqY7UZvRa9m3w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/5ebeb797976f4b134f89e7fc0f1f7cd5.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-jnj-stock-now-193728098.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-jnj-stock-now-193728098.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "KVUE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-16T18:39:00+00:00",
    "headline": "Kenvue Stock Tumbles on a New Challenge. It Isn’t Tylenol This Time.",
    "summary": "More than 3,000 people filed suit in the U.K. against a Kenvue subsidiary and Johnson & Johnson over baby powder.",
    "url": "https://www.barrons.com/articles/kenvue-stock-baby-powder-cancer-79538f4f?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "d327cccf-d5e7-32aa-9536-2873d187e961",
      "content": {
        "id": "d327cccf-d5e7-32aa-9536-2873d187e961",
        "contentType": "STORY",
        "title": "Kenvue Stock Tumbles on a New Challenge. It Isn’t Tylenol This Time.",
        "description": "",
        "summary": "More than 3,000 people filed suit in the U.K. against a Kenvue subsidiary and Johnson & Johnson over baby powder.",
        "pubDate": "2025-10-16T18:39:00Z",
        "displayTime": "2025-10-16T18:39:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/d327cccf-d5e7-32aa-9536-2873d187e961/kenvue-stock-tumbles-on-a-new.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/07788001113c7b9a9922d5f46e6e6ea6",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CsOvmlTk8ksEfoiGzprvSA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/07788001113c7b9a9922d5f46e6e6ea6.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sm8K0MdZVuOULgTe6ils8Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/07788001113c7b9a9922d5f46e6e6ea6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/kenvue-stock-baby-powder-cancer-79538f4f?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "KVUE"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-16T17:04:57+00:00",
    "headline": "Kenvue stock falls as UK talc lawsuits raise liability concerns",
    "summary": "Investing.com -- Kenvue (NYSE:KVUE) stock fell 5% Thursday as the consumer health company faces new legal challenges in the United Kingdom related to allegations that its talc products cause cancer.",
    "url": "https://finance.yahoo.com/news/kenvue-stock-falls-uk-talc-170457468.html",
    "source": "Investing.com",
    "provider": "yfinance",
    "raw": {
      "id": "47f0e350-17d6-3c4f-b42a-d6b5a85b35b6",
      "content": {
        "id": "47f0e350-17d6-3c4f-b42a-d6b5a85b35b6",
        "contentType": "STORY",
        "title": "Kenvue stock falls as UK talc lawsuits raise liability concerns",
        "description": "",
        "summary": "Investing.com -- Kenvue (NYSE:KVUE) stock fell 5% Thursday as the consumer health company faces new legal challenges in the United Kingdom related to allegations that its talc products cause cancer.",
        "pubDate": "2025-10-16T17:04:57Z",
        "displayTime": "2025-10-16T17:04:57Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "Investing.com",
          "url": "https://www.investing.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/kenvue-stock-falls-uk-talc-170457468.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/kenvue-stock-falls-uk-talc-170457468.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "KVUE"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-16T17:02:00+00:00",
    "headline": "J&J Bets on MedTech Growth With Orthopaedics Unit Spin-Off Plan",
    "summary": "J&J's surprise plan to spin off its Orthopaedics unit as DePuy Synthes is aimed at sharpening MedTech focus and boosting growth margins.",
    "url": "https://finance.yahoo.com/news/j-j-bets-medtech-growth-170200411.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "4efa2df0-5989-3507-ae80-e437ab606151",
      "content": {
        "id": "4efa2df0-5989-3507-ae80-e437ab606151",
        "contentType": "STORY",
        "title": "J&J Bets on MedTech Growth With Orthopaedics Unit Spin-Off Plan",
        "description": "",
        "summary": "J&J's surprise plan to spin off its Orthopaedics unit as DePuy Synthes is aimed at sharpening MedTech focus and boosting growth margins.",
        "pubDate": "2025-10-16T17:02:00Z",
        "displayTime": "2025-10-16T17:02:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/045ba7ae9e660e2a91686804eef7ab55",
          "originalWidth": 620,
          "originalHeight": 413,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7qxsqrZM8ueKEZZaMBimmA--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/045ba7ae9e660e2a91686804eef7ab55.cf.webp",
              "width": 620,
              "height": 413,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/z_Y9s.nod8y.0SuZhzp3mg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/045ba7ae9e660e2a91686804eef7ab55.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/j-j-bets-medtech-growth-170200411.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/j-j-bets-medtech-growth-170200411.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "KVUE"
            },
            {
              "symbol": "SYK"
            },
            {
              "symbol": "MDT"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-16T12:26:42+00:00",
    "headline": "Update: Johnson & Johnson Faces UK Lawsuit Over Talc Products",
    "summary": "(Updates with Johnson & Johnson's response in the fourth paragraph.) Johnson & Johnson (JNJ) is f",
    "url": "https://finance.yahoo.com/news/johnson-johnson-faces-uk-lawsuit-122642002.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "2189d613-bb22-3e58-9ec5-a44fea575da1",
      "content": {
        "id": "2189d613-bb22-3e58-9ec5-a44fea575da1",
        "contentType": "STORY",
        "title": "Update: Johnson & Johnson Faces UK Lawsuit Over Talc Products",
        "description": "",
        "summary": "(Updates with Johnson & Johnson's response in the fourth paragraph.) Johnson & Johnson (JNJ) is f",
        "pubDate": "2025-10-16T12:26:42Z",
        "displayTime": "2025-10-16T12:26:42Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-faces-uk-lawsuit-122642002.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-faces-uk-lawsuit-122642002.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "KVUE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-16T07:20:28+00:00",
    "headline": "J&J’s orthopedics selloff keeps all eyes on a thriving pharma portfolio",
    "summary": "As another J&J department bites the dust, leadership is focused on what’s working in the pharma business, and there’s plenty to see.",
    "url": "https://www.pharmavoice.com/news/jnj-orthopedics-selloff-pharmaceutical-stelara-darzalex-tremfya-spravato/802911/",
    "source": "Pharma Voice",
    "provider": "yfinance",
    "raw": {
      "id": "bba5e591-25cb-3d1b-a7d9-df691585f8d1",
      "content": {
        "id": "bba5e591-25cb-3d1b-a7d9-df691585f8d1",
        "contentType": "STORY",
        "title": "J&J’s orthopedics selloff keeps all eyes on a thriving pharma portfolio",
        "description": "",
        "summary": "As another J&J department bites the dust, leadership is focused on what’s working in the pharma business, and there’s plenty to see.",
        "pubDate": "2025-10-16T07:20:28Z",
        "displayTime": "2025-10-16T07:20:28Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharma_voice_330/9364ca12421a4d9c436593da0a1ff2c7",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "J&J CEO Joaquin Duato",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/N23KkyQYcvPfZchOJRGyNg--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharma_voice_330/9364ca12421a4d9c436593da0a1ff2c7.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Vj1FAgG5ixaHLH9_NCPoWA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharma_voice_330/9364ca12421a4d9c436593da0a1ff2c7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharma Voice",
          "url": "https://www.pharmavoice.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmavoice.com/news/jnj-orthopedics-selloff-pharmaceutical-stelara-darzalex-tremfya-spravato/802911/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/j-j-orthopedics-selloff-keeps-072028550.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "KVUE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-16T05:46:34+00:00",
    "headline": "J&J faces first UK lawsuits alleging its baby powder caused cancer",
    "summary": "<body><p>STORY: Johnson & Johnson is facing its first lawsuits in the United Kingdom over alleged cancer-causing talc products.</p><p>That comes as the drugmaker fights tens of thousands of similar claims in the United States.</p><p>Legal firm KP Law said it filed a lawsuit Tuesday at the English High Court on behalf of 3,000 people who say their ovarian cancer or other diseases were caused by using J&J's baby powder between 1965 and 2023.</p><p>The firm says J&J's talc products contained carcinogenic fibers, including asbestos which is often linked to mesothelioma, a deadly form of cancer.</p><p>The value of the lawsuit against J&J and a subsidiary of its former consumer health unit Kenvue, is estimated at just over $1.3 billion.</p><p>Kenvue said in a statement that J&J baby powder \"did not contain asbestos, and does not cause cancer\".</p><p>J&J stopped selling talc-based baby powder in the U.S. in 2020, switching to a cornstarch product.</p><p>It did the same in the UK in 2023.</p><p>The company has sought to resolve the tens of thousands of similar lawsuits in the U.S. through bankruptcy.</p><p>But federal courts rejected the strategy three times.</p></body>",
    "url": "https://finance.yahoo.com/video/j-j-faces-first-uk-054634753.html",
    "source": "Reuters Videos",
    "provider": "yfinance",
    "raw": {
      "id": "7cd07d36-ae7a-31b3-880a-76e577e5773f",
      "content": {
        "id": "7cd07d36-ae7a-31b3-880a-76e577e5773f",
        "contentType": "VIDEO",
        "title": "J&J faces first UK lawsuits alleging its baby powder caused cancer",
        "description": "<title><body><p>STORY: Johnson & Johnson is facing its first lawsuits in the United Kingdom over alleged cancer-causing talc products.</p><p>That comes as the drugmaker fights tens of thousands of similar claims in the United States.</p><p>Legal firm KP Law said it filed a lawsuit Tuesday at the English High Court on behalf of 3,000 people who say their ovarian cancer or other diseases were caused by using J&J's baby powder between 1965 and 2023.</p><p>The firm says J&J's talc products contained carcinogenic fibers, including asbestos which is often linked to mesothelioma, a deadly form of cancer.</p><p>The value of the lawsuit against J&J and a subsidiary of its former consumer health unit Kenvue, is estimated at just over $1.3 billion.</p><p>Kenvue said in a statement that J&J baby powder \"did not contain asbestos, and does not cause cancer\".</p><p>J&J stopped selling talc-based baby powder in the U.S. in 2020, switching to a cornstarch product.</p><p>It did the same in the UK in 2023.</p><p>The company has sought to resolve the tens of thousands of similar lawsuits in the U.S. through bankruptcy.</p><p>But federal courts rejected the strategy three times.</p></body></title>",
        "summary": "<body><p>STORY: Johnson & Johnson is facing its first lawsuits in the United Kingdom over alleged cancer-causing talc products.</p><p>That comes as the drugmaker fights tens of thousands of similar claims in the United States.</p><p>Legal firm KP Law said it filed a lawsuit Tuesday at the English High Court on behalf of 3,000 people who say their ovarian cancer or other diseases were caused by using J&J's baby powder between 1965 and 2023.</p><p>The firm says J&J's talc products contained carcinogenic fibers, including asbestos which is often linked to mesothelioma, a deadly form of cancer.</p><p>The value of the lawsuit against J&J and a subsidiary of its former consumer health unit Kenvue, is estimated at just over $1.3 billion.</p><p>Kenvue said in a statement that J&J baby powder \"did not contain asbestos, and does not cause cancer\".</p><p>J&J stopped selling talc-based baby powder in the U.S. in 2020, switching to a cornstarch product.</p><p>It did the same in the UK in 2023.</p><p>The company has sought to resolve the tens of thousands of similar lawsuits in the U.S. through bankruptcy.</p><p>But federal courts rejected the strategy three times.</p></body>",
        "pubDate": "2025-10-16T05:46:34Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/uu/api/res/1.2/S9Oknq9o_Hk_MjD2B4rlag--~B/aD03MjA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://cf-images.us-east-1.prod.boltdns.net/v1/jit/6415665815001/cdc0b811-004b-4360-b584-e5642d87575a/main/1280x720/38s272ms/match/image.jpg",
          "originalWidth": 1280,
          "originalHeight": 720,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rCYAYuGEzXs_Qm6ig8EHqw--~B/aD03MjA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://cf-images.us-east-1.prod.boltdns.net/v1/jit/6415665815001/cdc0b811-004b-4360-b584-e5642d87575a/main/1280x720/38s272ms/match/image.jpg.cf.webp",
              "width": 1280,
              "height": 720,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Fno7jq3tyYe4tBBZJheZGA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://cf-images.us-east-1.prod.boltdns.net/v1/jit/6415665815001/cdc0b811-004b-4360-b584-e5642d87575a/main/1280x720/38s272ms/match/image.jpg.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters Videos",
          "url": "http://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/j-j-faces-first-uk-054634753.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/j-j-faces-first-uk-054634753.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "KVUE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]